Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

BrightSpring Health Services Inc. (BTSGU)

  • Business News
  • June 11, 2025, 01:59 UTC
  • 8

BrightSpring Announces Pricing of Secondary Offering of Common Stock

Market reaction Comment Full text

Mirum Pharmaceuticals Inc (MIRM)

  • Business News
  • June 11, 2025, 00:40 UTC
  • 10

Mirum Pharma - Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

Mirum Pharmaceuticals Inc (MIRM)

  • Business News
  • June 11, 2025, 00:40 UTC
  • 8

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

Elevation Oncology Inc. (ELEV)

  • Business News
  • June 10, 2025, 22:58 UTC
  • 8

ELEVATION ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Elevation Oncology, Inc. - ELEV

Market reaction Comment Full text

Know Labs (KNW)

  • Business News
  • June 10, 2025, 22:58 UTC
  • 11

KNOW LABS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Know Labs, Inc. - KNW

Market reaction Comment Full text

ResMed Inc (RMD)

  • Business News
  • June 10, 2025, 22:36 UTC
  • 8

New SEC Form for ResMed Inc.

Market reaction Comment Full text

ResMed Inc (RMD)

  • Business News
  • June 10, 2025, 22:34 UTC
  • 9

ResMed Inc. Daily Stock Update

Market reaction Comment Full text

PepGen Inc. (PEPG)

  • Business News
  • June 10, 2025, 22:27 UTC
  • 8

Shareholder Alert: Robbins LLP Informs Investors of the PepGen Inc. Class Action

Market reaction Comment Full text

ArgenX Inc (ARGX)

  • Business News
  • June 10, 2025, 22:01 UTC
  • 8

argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease

Market reaction Comment Full text

Celularity Inc. (CELUW)

  • Business News
  • June 10, 2025, 21:19 UTC
  • 10

Celularity Announces Chief Financial Officer Transition

Market reaction Comment Full text
  • Previous
  • 257
  • 258
  • 259
  • 260
  • 261
  • Next

Search

News categories

  • Technical Exchange News(9542)
  • Event(407)
  • SEC News(156365)
  • FDA Approval(8929)
  • Company Report(721)
  • Business News(106169)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin